Accedi
Accedi
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrati
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

I Leader della Finanza

HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza 
Portrait de Seth L. Harrison
EtÓ : 61
Patrimonio pubblico : 15 583 147 USD
Principali societÓ : Akero Therapeutics, Inc. - Stoke Therapeutics, Inc.
Riassunto 
Seth L. Harrison is a businessperson who founded Tokai Pharmaceuticals, Inc. and Apple Tree Partners and who has been at the helm of 13 different companies. Dr. Harrison is Chairman of Cure Forward Corp., Chairman of Braeburn, Inc., Chairman at Braeburn Pharmaceuticals SPRL (a subsidiary of Braeburn, Inc.), Chairman of Marengo Therapeutics, Inc., Chairman for Limelight Bio, Inc., Chairman at Stoke Therapeutics, Inc., Chairman for Nereid Therapeutics, Inc., Chairman of Adendra Therapeutics Ltd., Chief Executive Officer of Apple Tree Life Sciences, Inc., Managing Partner at Apple Tree Partners, Chairman for Aethon Therapeutics, Inc. and Treasurer & Director at Syntimmune, Inc. Seth L. Harrison is also on the board of 15 other companies.

In his past career he held the position of Director at Aileron Therapeutics, Inc., Venture Partner at Sevin Rosen Bayless Management Co., General Partner of Oak Investment Partners and Chairman at Tokai Pharmaceuticals, Inc.

Seth L. Harrison received an undergraduate degree from Princeton University and an MBA and a doctorate from The Trustees of Columbia University in The City of New York.


Posti e reponsabilitÓ di Seth L. Harrison 
NomeTitolo Da
Akero Therapeutics, Inc.
(Biotecnologia)
Director 2017
Stoke Therapeutics, Inc.
(Biotecnologia)
Chairman 2015
Apple Tree Life Sciences, Inc. Chief Executive Officer -
Aethon Therapeutics, Inc. Chairman -
Adendra Therapeutics Ltd. Chairman -
Nereid Therapeutics, Inc. Chairman -
Limelight Bio, Inc. Chairman -
Marengo Therapeutics, Inc. Chairman -
Braeburn, Inc. Chairman -
Nine Square Therapeutics, Inc. Director -
Syntimmune, Inc. Treasurer & Director -
The Rockefeller Foundation Director -
Intergalactic Therapeutics, Inc. Director -
Replicate Bioscience, Inc. Director -
Apertor Pharmaceuticals, Inc. Director -
Ascidian Therapeutics, Inc. Director -
Initial Therapeutics Inc Director -
CleanSlate Centers, Inc. Director -
Galavant Therapeutics, Inc. Director -
Galvanize Therapeutics, Inc. Director -
Galaxy Medical, Inc. Director -
Braeburn Pharmaceuticals SPRL Chairman -
Tortoise Foundation Director -
Harrison Atelier Foundation Director -
Gala Therapeutics, Inc. Director -
Apple Tree Partners Founder & Managing Partner 1999


Participazioni di Seth L. Harrison 
NomeAzioni%Valorizzazione
Akero Therapeutics, Inc. (AKRO)
(Biotecnologia)
284 3640,61%15 583 147 USD
Stoke Therapeutics, Inc. (STOK)
(Biotecnologia)
00,0000%0 USD


Seth L. Harrison: network personale 
Le notizie pi¨ lette 
26/01Musk dice che i rivali cinesi "lavorano in modo più duro e intelligente".
MR
27/01L'ARK Innovation Fund di Wood è al passo con il miglior mese di sempre, grazie all'impennata dei titoli azionari
MR
26/01Arnault di LVMH respinge la questione della successione
MR
27/01Bill Ackman dice che il rapporto di Hindenburg su Adani Group è 'altamente credibile'.
MR
19/01Il CEO di JPMorgan Dimon vede i tassi di interesse andare oltre il 5% - CNBC
MR
19/01I lavoratori GM licenziati in India fanno causa all'azienda e al CEO Barra per il risarcimento non pagato
MR
20/01Musk è atteso al banco dei testimoni alla ripresa del processo per il tweet di Tesla
MR
04:53Il CFO del Gruppo Sony, Totoki, succederà a Yoshida come presidente - Nikkei
MR
31/01L'Italia prende in considerazione la sostituzione di Starace come amministratore delegato di Enel, dicono le fonti
MR
24/01Rupert Murdoch scarta la proposta di combinare Fox, News Corp
MR
Altre news


© 2023 People and Ownership :   
Seth L. Harrison : connessioni